SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on Financial Results09-11-2023
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on Financial ResultsSMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News Paper cutting of published financial resultsSMS PHARMACEUTICALS LTD. - 532815 - Related Party Transactions For The Half Year Ended 30Th September, 2023
Related Party Transactions for the half year ended 30th September, 2023SMS PHARMACEUTICALS LTD. - 532815 - Update On Pledge Of Shares Held In VKT Pharma Private Limited, Associate Company
update on pledge of shares held in VKT Pharma Private Limited, Associate CompanySMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Outcome for Outcome Of Board Meeting And Financial Results For The Second Quarter And Half Year Ended 30Th September, 2023
Outcome of Board Meeting and Financial Results for the second quarter and half year ended 30th September, 2023SMS PHARMACEUTICALS LTD. - 532815 - Outcome And Financial Results For The Quarter Ended 30Th September, 2023
Outcome and Financial Results for the quarter ended 30th September, 2023SMS PHARMACEUTICALS LTD. - 532815 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share CertificateSMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Investor's Conference CallSMS PHARMACEUTICALS LTD. - 532815 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of share certificateSMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for The Approval Of Financial Results For The Quarter Ended 30Th September, 2023
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve the financial results for the quarter ended 30th September, 2023